|
Alv Logo
Kategorier
  • Announcements
  • Scientific
Forfattere
  • CHRISTOFFER J. FALCHENBERG
  • RICHARD CRISPIN
Filter
Sorter
Nyest til eldst
Read more

Alv B AS files for patent protection on cancer vaccine technology

Alv B AS files for patent protection on cancer vaccine technology.

Alv B AS files for patent protection on cancer vaccine technology

Announcements
CHRISTOFFER J. FALCHENBERG - 11/29/2022
Read more

Alv B AS partners with Oncogene AS to identify canine gene targets for cancer vaccine development.

Alv B AS partners with Oncogene AS to identify canine gene targets for cancer vaccine development.

Alv B AS partners with Oncogene AS to identify canine gene targets for cancer vaccine development.

RICHARD CRISPIN - 11/15/2022
Read more

Alv B AS is happy to announce its collaboration with Diakonos Oncology Corporation.

Alv B has signed a licensing agreement with Diakonos for exclusive rights of Tumor Prep in the European market, with rights of first refusal for the global market.

Alv B AS is happy to announce its collaboration with Diakonos Oncology Corporation.

Announcements
RICHARD CRISPIN - 11/7/2022
Read more

Alv B announces co-operation with AJ Vaccines for cancer vaccines

AJ Vaccines lends support to Alv B for upcoming cancer vaccine trial in dogs, by supplying key component free of charge.

Alv B announces co-operation with AJ Vaccines for cancer vaccines

CHRISTOFFER J. FALCHENBERG - 9/16/2022
Read more

Francesca Lockwood joins the team

We are happy to announce that Francesca Lockwood has joined the team with Alv B.

Francesca Lockwood joins the team

Announcements
Scientific
CHRISTOFFER J. FALCHENBERG - 1/11/2022
Read more

Steven Verhaegen joins the team

Steven Verhaegen joined the ALV-B team as Senior Industrial Scientist in December 2021. He will use his extensive cell biology knowledge to help the team develop new therapeutic approaches and...

Steven Verhaegen joins the team

Announcements
CHRISTOFFER J. FALCHENBERG - 12/21/2021
Read more

FRANCESCA GATTI JOINS THE TEAM

Francesca er celle- og molekylærbiolog med PhD i Bioteknologi med fokus på immunologi og biomaterialer, fra Universitetet i Salento og Harvard Medical School.

FRANCESCA GATTI JOINS THE TEAM

Announcements
CHRISTOFFER J. FALCHENBERG - 12/7/2021
Read more

ALV B RECEIVES GOVERNMENT GRANT

We are pleased to announce that “Innovation Norway” has offered Alv B a grant for the commercialization of Alv B’s product range within immunotherapy, and diagnostics for cats and dogs with cancer.

ALV B RECEIVES GOVERNMENT GRANT

Announcements
CHRISTOFFER J. FALCHENBERG - 12/6/2021
Read more

ZANINA GRIEG JOINS ALV B

We are happy to announce that Zanina Grieg has taken on the role as Senior Engineer with Alv B.

ZANINA GRIEG JOINS ALV B

Announcements
CHRISTOFFER J. FALCHENBERG - 12/5/2021
Read more

David Kunke PhD Joins Advisory Board

We are happy to announce that David Kunke, Ph.D. has joined Alv B’s advisory board.

David Kunke PhD Joins Advisory Board

Announcements
CHRISTOFFER J. FALCHENBERG - 12/4/2021
Read more

Birthe Mikkelsen joins the team

Birthe Mikkelsen is a senior engineer with more than 25 years of experience from academic research. She worked more than 20 years at the Oslo University Hospital, and before that...

Birthe Mikkelsen joins the team

Announcements
CHRISTOFFER J. FALCHENBERG - 9/3/2021

Contact us

Alv B © 2022